SET Announcements
The latest company disclosures have been updated, offering investors and stakeholders timely access to essential information.
31 January 2020
Report of the utilization of capital increase from IPO
06 December 2019
Rights of Shareholders to propose agenda and to nominate candidates to be elected as Directors
20 November 2019
Notification of acquisition of 83.33% Equity Shares of PT Futamed Pharmaceuticals (Revised)
15 November 2019
Notification of acquisition of 83.33% Equity Shares of PT Futamed Pharmaceuticals
14 November 2019
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2019
14 November 2019
Reviewed financial performance Quarter 3 (F45)
14 November 2019
Financial Statement Quarter 3/2019 (Reviewed)
14 August 2019
Reviewed Quarter 2 and Consolidated F/S (F45-3)
14 August 2019
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2019
14 August 2019
Financial Statement Quarter 2/2019 (Reviewed)
14 August 2019
Declaration of interim dividend of 2019
30 July 2019
